BeiGene (ONC) EBITDA

Annual EBITDA

-$396.44 M
+$723.62 M+64.61%

December 31, 2024

Summary

Performance

1-Year Change

+64.61%

3-Year Change

+71.53%

5-Year Change

+57.88%

15-Year Change

-323.1%

ONC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3%
ONC annual EBITDA is higher than 3% of companies in Healthcare sector

High & Low

All-time High

-$3.15 M

3-Year Low

-$1.72 B

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ONC previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ONC next annual earnings announcement has not yet been scheduled

OtherONCprofitabilitymetrics:

Annual Revenue

$3.81 B
ONC annual revenue is $3.81 billion

Annual Net Income

-$644.79 M
ONC annual net profit is -$644.79 million

Annual EBIT

-$568.20 M
ONC annual earnings before interest & taxes is -$568.20 million

Annual EPS

-$6.11
ONC annual earnings per share is -$6.11

Quarterly EBITDA

-$29.18 M
+$19.79 M+40.42%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+91.89%

3-Year Change

+91.89%

5-Year Change

+91.89%

ONC Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

16.54%
ONC quarterly EBITDA is higher than 16.54% of companies in Healthcare sector

High & Low

All-time High

$116.20 M
ONC quarterly EBITDA is currently -125.11% below its historical high of $116.20 million

3-Year Low

-$450.61 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ONC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ONC next earnings announcement is scheduled for May 8, 2025

OtherONCprofitabilitymetrics:

Quarterly Revenue

$1.13 B
ONC quarterly revenue is $1.13 billion

Quarterly Net Income

-$151.88 M
ONC quarterly net profit is -$151.88 million

Quarterly EBIT

-$79.42 M
ONC quarterly earnings before interest & taxes is -$79.42 million

Quarterly EPS

-$1.43
ONC quarterly earnings per share is -$1.43

TTM EBITDA

-$396.44 M
+$330.80 M+45.49%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+64.61%

3-Year Change

+64.61%

5-Year Change

+64.61%

ONC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

3.15%
ONC TTM EBITDA is higher than 3.15% of companies in Healthcare sector

High & Low

All-time High

-$7.90 M

3-Year Low

-$1.90 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ONC previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
ONC next earnings announcement is scheduled for May 8, 2025

OtherONCprofitabilitymetrics:

TTM Revenue

$3.81 B
ONC TTM revenue is $3.81 billion

TTM Net Income

-$644.79 M
ONC TTM net profit is -$644.79 million

TTM EBIT

-$568.20 M
ONC TTM earnings before interest & taxes is -$568.20 million

TTM EPS

-$6.24
ONC TTM earnings per share is -$6.24

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$396.44 M
ONC annual EBITDA is -$396.44 million

Annual Net Income

-$644.79 M
ONC annual net profit is -$644.79 million

Annual Interest Expense

-
ONC annual interest expense value is unknown

Annual Income Tax

$111.78 M
ONC annual income tax is $111.78 million

Annual D&A

$171.76 M
ONC annual depreciation & amortization is $171.76 million

ONC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+64.6%+91.9%+64.6%
3 y3 years+71.5%+91.9%+64.6%
5 y5 years+57.9%+91.9%+64.6%

ONC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+77.0%at high+93.5%at high+79.1%
5 y5-yearat high+77.0%-136.6%+94.8%at high+79.1%
alltimeall time<-9999.0%+77.0%-125.1%+94.8%-4915.6%+79.1%

BeiGene EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$396.44 M(-64.6%)
-$29.18 M(-40.4%)
-$396.44 M(-45.5%)
Sep 2024
-
-$48.97 M(-40.4%)
-$727.23 M(-8.0%)
Jun 2024
-
-$82.23 M(-65.2%)
-$790.72 M(-21.3%)
Mar 2024
-
-$236.06 M(-34.4%)
-$1.00 B(-10.3%)
Dec 2023
-$1.12 B(-35.0%)
-$359.98 M(+220.1%)
-$1.12 B(-7.5%)
Sep 2023
-
-$112.46 M(-62.1%)
-$1.21 B(-20.4%)
Jun 2023
-
-$296.38 M(-15.6%)
-$1.52 B(-7.7%)
Mar 2023
-
-$351.25 M(-22.1%)
-$1.65 B(-4.4%)
Dec 2022
-$1.72 B(+23.8%)
-
-
Dec 2022
-
-$450.61 M(+6.7%)
-$1.72 B(-5.9%)
Sep 2022
-
-$422.16 M(-0.4%)
-$1.83 B(-1.5%)
Jun 2022
-
-$423.94 M(-0.6%)
-$1.86 B(-2.1%)
Mar 2022
-
-$426.69 M(-23.6%)
-$1.90 B(+36.4%)
Dec 2021
-$1.39 B(-14.4%)
-$558.62 M(+24.1%)
-$1.39 B(+6.2%)
Sep 2021
-
-$450.15 M(-2.8%)
-$1.31 B(+1.4%)
Jun 2021
-
-$463.31 M(-680.6%)
-$1.29 B(+9.5%)
Mar 2021
-
$79.80 M(-116.7%)
-$1.18 B(-27.4%)
Dec 2020
-$1.63 B(+72.7%)
-$477.08 M(+10.5%)
-$1.63 B(+6.3%)
Sep 2020
-
-$431.79 M(+23.0%)
-$1.53 B(+8.8%)
Jun 2020
-
-$351.01 M(-4.1%)
-$1.41 B(+23.6%)
Mar 2020
-
-$366.01 M(-3.8%)
-$1.14 B(+20.8%)
Dec 2019
-$941.27 M
-$380.55 M(+23.5%)
-$941.27 M(+12.3%)
DateAnnualQuarterlyTTM
Sep 2019
-
-$308.24 M(+275.3%)
-$838.17 M(+23.5%)
Jun 2019
-
-$82.14 M(-51.8%)
-$678.58 M(-10.4%)
Mar 2019
-
-$170.34 M(-38.6%)
-$757.15 M(+8.9%)
Dec 2018
-$695.38 M(+642.1%)
-$277.44 M(+86.6%)
-$695.38 M(+33.8%)
Sep 2018
-
-$148.66 M(-7.5%)
-$519.68 M(+103.9%)
Jun 2018
-
-$160.71 M(+48.0%)
-$254.82 M(+68.1%)
Mar 2018
-
-$108.56 M(+6.7%)
-$151.59 M(+61.8%)
Dec 2017
-$93.70 M(-18.6%)
-$101.74 M(-187.6%)
-$93.70 M(+225.9%)
Sep 2017
-
$116.20 M(-302.2%)
-$28.75 M(-84.0%)
Jun 2017
-
-$57.48 M(+13.4%)
-$179.28 M(+22.9%)
Mar 2017
-
-$50.68 M(+37.7%)
-$145.93 M(+26.7%)
Dec 2016
-$115.15 M(+108.6%)
-$36.80 M(+7.2%)
-$115.15 M(+9.0%)
Sep 2016
-
-$34.32 M(+42.2%)
-$105.67 M(+24.8%)
Jun 2016
-
-$24.14 M(+21.3%)
-$84.64 M(+29.2%)
Mar 2016
-
-$19.89 M(-27.2%)
-$65.50 M(+18.7%)
Dec 2015
-$55.20 M(+288.7%)
-$27.32 M(+105.4%)
-$55.20 M(+74.1%)
Sep 2015
-
-$13.30 M(+166.2%)
-$31.70 M(+20.5%)
Jun 2015
-
-$5.00 M(-47.9%)
-$26.31 M(+23.4%)
Mar 2015
-
-$9.59 M(+151.5%)
-$21.31 M(+81.9%)
Dec 2014
-$14.20 M(+351.2%)
-$3.81 M(-51.7%)
-$11.72 M(+48.3%)
Sep 2014
-
-$7.90 M
-$7.90 M
Dec 2013
-$3.15 M
-
-

FAQ

  • What is BeiGene annual EBITDA?
  • What is the all time high annual EBITDA for BeiGene?
  • What is BeiGene annual EBITDA year-on-year change?
  • What is BeiGene quarterly EBITDA?
  • What is the all time high quarterly EBITDA for BeiGene?
  • What is BeiGene quarterly EBITDA year-on-year change?
  • What is BeiGene TTM EBITDA?
  • What is the all time high TTM EBITDA for BeiGene?
  • What is BeiGene TTM EBITDA year-on-year change?

What is BeiGene annual EBITDA?

The current annual EBITDA of ONC is -$396.44 M

What is the all time high annual EBITDA for BeiGene?

BeiGene all-time high annual EBITDA is -$3.15 M

What is BeiGene annual EBITDA year-on-year change?

Over the past year, ONC annual EBITDA has changed by +$723.62 M (+64.61%)

What is BeiGene quarterly EBITDA?

The current quarterly EBITDA of ONC is -$29.18 M

What is the all time high quarterly EBITDA for BeiGene?

BeiGene all-time high quarterly EBITDA is $116.20 M

What is BeiGene quarterly EBITDA year-on-year change?

Over the past year, ONC quarterly EBITDA has changed by +$330.80 M (+91.89%)

What is BeiGene TTM EBITDA?

The current TTM EBITDA of ONC is -$396.44 M

What is the all time high TTM EBITDA for BeiGene?

BeiGene all-time high TTM EBITDA is -$7.90 M

What is BeiGene TTM EBITDA year-on-year change?

Over the past year, ONC TTM EBITDA has changed by +$723.62 M (+64.61%)